- October 23, 2015Read more
Cohen Veterans Bioscience CEO & President, Dr. Magali Haas, participated in the CNS Summit 2015, which convened from October 8-11 in Boca Raton, Florida. There, Dr. Haas lent her extensive expertise in pharmaceutical strategy, clinical research, and biotechnology to the Keynote Session, “What Will be the Impact of Silicon Valley on Drug Development?”
- February 1, 2015Read more
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.
- October 20, 2014Read more
2014 KEY OPINION LEADER PROGRAM Thought leaders from industry, academia, government and medical research foundations share their insights on the opportunities and challenges that impact the discovery and development of new therapies. FRESH PERSPECTIVES AND NEW OPPORTUNITIES IN ALZHEIMER’S DISEASE THERAPEUTIC DEVELOPMENT More than 5 million Americans suffer from Alzheimer’s disease today, and without new drugs to prevent or halt